Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining

European Journal of Cancer

Volumn 32, Issue 2, 1996, Pages 363-365

  Thorban, S ^a   Roder, J D ^a   Pantel, K ^b   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokeratins; Immunocytochemistry; Micrometastasis; Monoclonal antibodies; Pancreatic carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKERATIN; MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW; CLINICAL ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BONE MARROW NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0029872858     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00586-2     Document Type: Article

References (15)

1. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993, 193, 68-73.
2. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991, 17, 167-172.
3. Zerbi A, Balzano G, Bottura R, Di Carlo V. Reliability of pancreatic cancer staging classifications. Int J Pancreatol 1994, 15, 13-18.
4. Gudjonsson B. Cancer of the pancreas. Cancer 1987, 60, 2284-2303.
5. Höfler H. Prognosefaktoren beim Pancreascarcinom. Chirurg 1994, 65, 253-257.
6. Roder JD, Siewert JR. Analyse prognoseassoziierter Faktoren beim Pankreaskopf- und periampullärem Carcinom. Chirurg 1992, 63, 410-415.
7. Schlimok G, Funke I, Holtzmann B, et al. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987, 84, 8672-8676.
8. Lindemann F, Schlimok G, Dischedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer cells. Lancet 1992, 340, 685-689.
9. Pantel K, Itzbicki JR, Angstwurm M, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993, 53, 1027-1031.
10. Schlimok G, Funke I, Pantel K, et al. Micrometastic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991, 27, 1461-1465.
11. Cordell J, Richardson TC, Pulford KAF, et al. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985, 52, 347-354.
12. Riethmüller G, Schlimok G, Lehmann JM, et al. Immunological analysis of micrometastases and the metastatic phenotype of human tumours. In Melchers F, et al., eds. Progress in Immunology, 7, Berlin, Springer, 1989, 1079-1086.
13. Riethmüller G, Johnson JP. Monoclonal antibodies in the detection and therapy of micrometastic cancers. Curr Opin Immunol 1992, 4, 647-655.
14. Gatter KC, Abdulaziz Z, Beverly P, et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 1982, 35, 1253-1267.
15. Juhl H, Stritzel M, Wroblewski A, et al. Immunocytological detection of micrometastic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994, 57, 1-6.